http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31766037

Outgoing Links

Predicate Object
contentType Journal Article|Published Erratum
endingPage 839
issn 1875-8908
1387-2877
issueIdentifier 2
pageRange 839-839
publicationName Journal of Alzheimer's disease : JAD
startingPage 839
bibliographicCitation Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis. 2019;68(2):839. PMID: 30932889; PMCID: PMC7990406.
date 2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.3233/jad-189016
https://pubmed.ncbi.nlm.nih.gov/30932889
https://pubmed.ncbi.nlm.nih.gov/PMC7990406
isPartOf https://portal.issn.org/resource/ISSN/1875-8908
https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72307
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385

Total number of triples: 23.